JPRN-UMIN000007715已完成1 期
PET measurement of hepatobiliary transport of Telmisartan in a therapeutic dose using [11C]Telmisartan in normal subjects as a determinant of nonlinear pharmacokinetics. - Pharmacokinetics of [11C]Telmisartan under oral therapeutic dose in healthy volunteers (TEL-1B).
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Renal artery stenosis, bilaterally or unilaterally after nephrectomy 2. Hyperkalemia 3. Liver or renal dysfunction 4. Cerebrovascular disorders 5. Hypotension 6. Severe bradycardia, or WPW or LGL syndrome by ECG 7. Medication or dietary supplement including St. John's wort within 7 days prior to PET study
研究者
相似试验
已完成
1 期
PET measurement of hepatobiliary transport of Telmisartan in a therapeutic dose using [11C]Telmisartan in normal subjects as a determinant of nonlinear pharmacokinetics.JPRN-UMIN000004019Foundation for Biomedical Research and Innovation10
已完成
不适用
PET Imaging-Based Evaluaion of Hepaobiliary transport in Humans with [18F]PTVHealthy adultJPRN-UMIN000030049RIKEN Center for Biosystems Dynamics Research8
已完成
不适用
Potential detectability of blood flow in hepatocellular carcinoma using contrast-enhanced ultrasonography with Sonazoid (Comparison with transvenous contrast-enhanced computed tomography or computed tomography with angiography)Hepatocellular carcinomaJPRN-UMIN000015389Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology100
招募中
不适用
Flushing of internalized percutaneous transhepatic biliary drainage cathetersbiliary obstructionNL-OMON54445Erasmus MC, Universitair Medisch Centrum Rotterdam91
招募中
不适用
oninvasive Evaluation of Hepatic Hemodynamics Using Xe Computed Tomographyiver disease (acute hepatitis, Chronic hepatitis, liver cirrhosis, hepatic failure, etc) Liver tumor (hepatocellular carcinoma, cholangiocellular carcinoma, metastatic liver tumor, etc)JPRN-UMIN000008078St. Marianna University, School of Medicine, Department of Internal Medicine, Division of Gastroenterology & Hepatology1,000
